Coumarin-based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors.

Autor: Jonnalagadda S; University of Nebraska Medical Center, Pharmaceutical Sciences, UNITED STATES., Duan L; University of Pennsylvania, Systems Pharmacology and Translational Therapeutics, UNITED STATES., Dow L; University of Nebraska Medical Center, Pharmaceutical Sciences, UNITED STATES OF AMERICA., Boligala G; Texas Tech University Health Sciences Center, Cancer Center, UNITED STATES., Kosmacek E; University of Nebraska Medical Center, Boichemistry and Molecular Biology, UNITED STATES., McCoy K; Texas Tech University Health Sciences Center, Cancer Center, UNITED STATES., Oberley-Deegan R; University of Nebraska Medical Center, Biochemistry and Molecular Biology, UNITED STATES., Chhonker Y; University of Nebraska Medical Center, Pharmacy Practice, UNITED STATES., Murry D; University of Nebraska Medical Center, Pharmacy Practice, UNITED STATES., Reynolds CP; Texas Tech University Health Sciences Center, Cancer Center, UNITED STATES., Maurer B; Texas Tech University Health Sciences Center, Cancer Center, UNITED STATES., Penning T; University of Pennsylvania, Systems Pharmacology and Translational Therapeutics, UNITED STATES., Trippier P; University of Nebraska Medical Center College of Pharmacy, Department of Pharmaceutical Sciences, 601 Saddle Creek Road, 68106, Omaha, UNITED STATES OF AMERICA.

Publikováno v: ChemMedChem [ChemMedChem] 2024 Jul 08, pp. e202400081. Date of Electronic Publication: 2024 Jul 08.